News Category: Health & Medical

– Automotive-grade product offers a reliable, repeatable and versatile solution that can be scaled up in line with specific customer requirements Interplex [https://interplex.com/e-mobility/?utm_source=press_release&utm_campaign=e_mobility&utm_content=multi-row_BTB_press_release] a world leader in designing and manufacturing interconnect and mechanical products, is successfully addressing the growing market demand for high-density interconnects in challenging application scenarios. The company has just released its Multi-Row … Continued

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organisation (CRO-CDMO)(https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=stephen-h-joins-slsc), today announced the joining of Stephen Hermitage (Steve) as Vice President, CMC. In this role Steve will join the global R&D leadership team at Sai Life Sciences, where he will add further deep scientific, process development and drug development experience to the … Continued

RELIEF THERAPEUTICS Holding SA (SIX: RLF) (OTCQB: RLFTF) (RLFTD) (“Relief”), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent protected products in selected specialty, rare and ultra-rare disease areas on a global basis, today announced that its wholly owned subsidiary APR Applied Pharma Research SA (“APR”) has been nominated as a finalist in … Continued

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has entered into a definitive agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma … Continued

A new global study launched during World Antimicrobial Awareness Week (WAAW, 18-24 November) shows a high dependence on antibiotics for treating respiratory conditions like sore throat, which is helping to fuel antibiotic resistance – the third leading cause of death worldwide, associated with 4.95 million deaths a year. The Sore Throat & Antibiotic Resistance (STAR) … Continued

Global children’s contest launched on World Inventors Day to raise awareness of hearing loss and the benefits of treatment Photo – https://mma.prnewswire.com/media/1946442/Aim_high_for_science.jpg Logo – https://mma.prnewswire.com/media/1860202/MED_EL_Logo.jpg MED-EL, a leading provider and inventor of hearing implant systems, today launched its annual worldwide search for inventions of the future through a global children’s contest, ideas4ears [ https://www.ideas4ears.org/enter/?utm_source=media&utm_medium=referral&utm_campaign=ideas4ears-launch2021 ]. … Continued

The world’s first simultaneous multi-channel/multi-nuclear 11.74T MRI system is currently under development at Gachon University Gil Medical Center (GUGMC). In the first Half of 2022 GUGMC successfully completed the Site Acceptance Test of the Magnet, which is a core part of the brain-specific ultra-precision 11.74T MRI that is being jointly developed with ASG Superconductors (ASG) … Continued

In a landmark new Global State of Tobacco Harm Reduction (GSTHR) report, experts are calling on global policymakers to seize the opportunity to bring about an end to smoking, which every year kills eight million people worldwide. Despite years of investment and effort, international tobacco control measures have stalled: the number of smokers has remained … Continued

Alphyn Biologics ( https://c212.net/c/link/?t=0&l=en&o=3709054-1&h=2795132862&u=https%3A%2F%2Falphynbiologics.com%2F&a=Alphyn+Biologics ), a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today that it has completed the first cohort of its Phase2a clinical trial of AB-101a, a topical therapeutic candidate for mild-to-moderate atopic dermatitis (AD) in adults and children as young as 2 years old. The first cohort enrolled AD patients without … Continued